tRNALYS is selectively incorporated into HIV-1 particles. We have measured the ratio of tRNALYS molecules to copies of genomic RNA in viral RNA samples and have calculated that HIV-1 contains approximately eight molecules of tRNA3YS per two copies of genomic RNA. We have also obtained evidence that the Pr1609'&P°p recursor is involved in primer tRNA3LYS incorporation into virus. First, selective tRNALYS incorporation and wild-type amounts of tRNALYS were maintained in a protease-negative virus unable to process Pr55gag and Pr1609'9-P°precursors, indicating that precursor processing was not required for primer tRNA incorporation.
Second, viral particles containing only unprocessed Pr559'9 protein did not selectively incorporate tRNALYS, while virions containing both unprocessed Pr551ag and Pr1609g9°' proteins demonstrated select tRNALYS packaging. Third, studies with a proviral mutant containing a deletion of most of the reverse transcriptase sequences and approximately one-third of the integrase sequence in the Pr16W'9-P°precursor resulted in the loss of selective tRNA incorporation and an eightfold decrease in the amount of tRNA3LYS per two copies of genomic RNA. We have also confirmed herein finding of a previous study which indicated that the primer binding site is not required for the selective incorporation of tRNALYS.
A limited number of tRNAs derived from the infected host cell are packaged into retroviruses during virus assembly (9, 11, 24, 31, 33) . One of these is termed the primer tRNA because it is used to prime the reverse transcriptase (RT)-catalyzed synthesis of retroviral minus-strand DNA. All members of the avian sarcoma and leukosis virus group examined to date use tRNATrP as primer for reverse transcription (10, 14, 26, 33, 39, 40) , whereas murine leukemia virus (MuLV) employs tRNAPrO (13, 24, 37) , and mouse mammary tumor virus utilizes tRNALYS (25, 38) . The 3'-terminal 18 nucleotides of primer tRNA are complementary to a region near the 5' end of the 35S RNA, termed the primer binding site (PBS). The sequence of this site in human immunodeficiency virus type 1 (HIV-1) suggests that the primer tRNA in this virus is also tRNALYS, one of the three major tRNALYS isoacceptors in mammalian cells (28, 29) .
Retroviral tRNA is found either in a free state or associated with the viral genome (8, 10, 11, 38, 39) . When the viral 70S RNA complex is used to direct DNA synthesis catalyzed by RT, one of these bound tRNAs, more tightly associated than the others, serves as a primer for DNA synthesis (11, 18, 24, 37, 39) . In HIV-1, the tightly associated tRNA is tRNA LS (16) .
During viral assembly, tRNA packaging is selective, and in HIV-1 produced by transfecting COS cells with HIV-1 proviral DNA, the tRNALYs isoacceptors, tRNA2 and tRNA3YS are the major-abundance tRNAs packaged (16) . These tRNAs are selected from over 100 different tRNA isoacceptor species in the cytoplasm, and we are investigating the mechanism responsible for this process. Previous work has indicated that the reduction or absence of viral genomic RNA incorporation does not affect primer tRNA incorporation into virions (20, 26) . Because retrovirus are assembled by using Pr55Ma& and Pr1609a9-J°precursors which are not cleaved until after viral budding (17, 41) , it is likely that the selection of tRNALYS occurs by the binding of tRNALYS to either of these proteins. PrMSag contains the amino acid sequence for nucleocapsid protein (NC), and Pr1609agsPo contains the amino acid sequences for NC and RT. Both NC and RT (in their fully processed forms) have been shown to bind to tRNA3'YS in vitro (1, 27, 32) . The absence of RT has also been reported to affect the incorporation of primer tRNA in both murine (21) 25 in the protease region (12) . SVC21 MSC1 (D) is an in-frame RT deletion mutant derived from SVC21 BH10 as described in Materials and Methods. The dashed line in the SVC21 MSC1 diagram indicates the deletion region. pSVGAG-RRE-R (E) and pSVGAGPOL-RRE-R P( -) (F), which serve as templates for the synthesis of Pr55gag and unprocessed P16099ag-Po, respectively, were constructed as previously described (34, 35) .
quence. SVC21 P(-) differs from SVC21 BH10 by a single point mutation at position 25 of the protease region, converting Asp-25 to Arg-25. Transfection of SVC21 P(-) produces noninfectious viral particles containing wild-type genomic RNA and unprocessed precursor proteins Pr55rag and Pr16G0agIPo (12) . Both SVC21 BH10 and SVC21 P(-) were gifts from E. Cohen, University of Montreal.
SVC21 MSC1 contains an in-frame deletion of RT and approximately one-third of the integrase sequence and was derived from SVC21 BH10. SVC21 BH10 was completely digested with the restriction enzyme MSC1 (New England Biolabs). The resulting 12-kb fragment, containing the plasmid vector and deleted HIV-1 genome, was fractionated by agarose electrophoresis and, after extraction from the gel, further purified by using a mini-spin column and phenol-chloroform extraction. The fragment was ligated with T4 DNA ligase (Pharmacia). DNA sequencing was performed to confirm the deletion.
pSVGAG-RRE-R and pSVGAGPOL-RRE-R P(-) were previously described (34, 35) . Viral production from these two plasmids requires cotransfection with the Rev protein expression vector pCMV-rev. Cotransfection of pSVGAG-RRE-R with pCMV-rev produces virus-like particles containing unprocessed Pr55gag precursor protein, while cotransfection of pSVGAGPOL-RRE-R P(-) with pCMV-rev produces viruslike particles containing unprocessed Pr55gag and Pr160`ag9Po.
All restriction and modification enzymes were used as specified by the manufacturer.
Production of wild-type and mutant HIV-1. COS-7 cells were transfected with wild-type and mutant proviral DNAs by the calcium phosphate method as previously described (17) . Virus was isolated from the cell culture medium 63 h posttransfection. The supernatant was first centrifuged in a Beckman GS-6R rotor at 3,000 rpm for 30 min, and the virus was then pelleted from the resulting supernatant by centrifuging in a Beckman Ti45 rotor at 35,000 rpm for 1 h. The viral pellet was then purified by centrifugation at 26,500 rpm for 1 h through 15% sucrose onto a 65% sucrose cushion, using a Beckman SW41 rotor.
Isolation of viral RNA and human placental tRNALYS isoacceptors. Total viral RNA was extracted from viral pellets by the guanidinium isothiocyanate procedure (4). The purification of tRNALYS and tRNALys from human placenta was performed as previously described (16) . The term tRNALYs refers to a population of two tRNALYS species which differ by one base pair in the anticodon stem (28) . In this report, spots 1 and 2 are collectively referred to as tRNALY, since we have not sufficiently characterized these two species to distinguish tRNALYS from tRNALYs (16 The RNA was labeled with 32pCp as previously described (3, 18) . After labeling, free 32pCp was removed from the labeled macromolecules either by using homemade Sephadex G-50 (Pharmacia) spin columns equilibrated with TE buffer (10 mM Tris [pH 7.5], 1 mM EDTA) or during the electrophoresis run. Before analysis by polyacrylamide gel electrophoresis (PAGE), the samples were heated at 90°C for 2 min.
One-dimensional (1D) and 2D PAGE. Viral RNA was electrophoresed at 4°C in a Hoefer SE620 gel electrophoresis apparatus. Gel size was 14 by 32 cm. The first dimension was run in a 10% polyacrylamide-7 M urea gel for approximately 16 h at 800 V, until the bromophenol blue dye was beginning to elute from the bottom of the gel. After autoradiography, the piece of gel containing RNA was cut out, embedded in a J. VlIROL.
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second gel (20% polyacrylamide-7 M urea), run for 30 h (25 W limiting), and then subjected to autoradiography. All electrophoretic runs were carried out in 0.5 x TBE (1 x TBE is 5 mM Tris, 5 mM boric acid, and 1 mM Na2EDTA). The electrophoretic gel patterns shown in this report show only lowmolecular-weight RNA, since the high-molecular-weight viral genomic RNA cannot enter the polyacrylamide gels. Furthermore, these patterns represent only the most abundant tRNA species present, since the high specific activities of the labeled tRNAs used will reveal more minor-abundance species with longer film exposures.
The signal intensity of each radioactive low-molecularweight RNA species in the 2D PAGE RNA pattern was determined with a Phosphorlmager (Bio-Rad, Toronto, Ontario, Canada).
Measurement of tRNA3YS by RNA-DNA hybridization. To measure the amount of tRNA3Ys in viral RNA, we synthesized an 18-mer DNA oligonucleotide complementary to the 3' 18 nucleotides of tRNA3LS (5'-TGGCGCCCGAACAGGGAC-3'). This probe hybridizes specifically with tRNA3YS (16, 17) and was hybridized to dot blots on To analyze the low-molecular-weight RNAs present in viral particles, total RNA was extracted, end labeled, and subjected to 2D PAGE as described in Materials and Methods. Figure 2 shows the 2D PAGE patterns of tRNAs extracted from normal COS-7 cells as well as from virus particles produced from the cells transfected with the different vectors. Figure 2 -A shows the tRNA extracted from uninfected COS-7 cells. Previous studies have identified spots 1 and 2 as tRNAlLY and spot 3 as tRNALYS (16) . To quantitate the amount of tRNA present in each spot, the gel was subjected to phosphor-imaging analysis. Table 1 shows the quantitation of the tRNALYs spots from the various gels. In untransfected COS-7 cells ( Fig. 2A) , approximately 6% of the cellular tRNA was represented by tRNALYS, and the tRNALYS ratio was close to 1 ( Table 1 ). In contrast, in wild-type virus (Fig. 2B) Fig. 2 . Spots refcr to those in Fig. 2. bSee Fig. 1 . particles produced from a proviral clone lacking an active viral protease [pSVC21 P(-)]. This clone contains an inactive protease due to a Asp-25-to-Arg-25 change in the active site, and the particles produced from transfected cells remain in the immature form containing only unprocessed Pr55gag and Pr16WQag-Po (12) . As shown in Fig. 2C and Table 1 , approximately 50% of the low-molecular-weight RNA is tRNALYS, with a tRNAL,S/tRNALYs ratio equal to 1.0.
Pr16W'g-P" is the most likely precursor protein to be involved in tRNALYS packaging because it contains the sequences for RT, a protein whose mature form has been shown to interact with tRNALYs in vitro (1, 32) . To investigate the role of Pr1609-P" in select tRNALYs packaging, we transfected COS cells with a proviral DNA (pSVC21 MSC1) which is missing 95% of RT sequences and approximately one-third of the integrase sequence (Fig. 1C) . In this mutant, Pr559'" is processed. Figure 2D shows the low-molecular-weight RNA pattern in the virus particles produced, and the Phosphor-imaging analysis of the gel is presented in that while the tRNALYs isoacceptors are present in the virus, they are not selectively packaged. The relative concentration of the tRNALY, in the virus is similar to that found in the cytoplasm of nontransfected cells, i.e., 4.2%. The deletion used in this experiment was too large to allow mapping of the precise region inPr-60¢g~-°" involved in selecting tRNALYS for incorporation into the virus, but these data clearly demonstrate the importance ofPrl60¢QagPo in the selection process.
On the other hand, viral particles containing only unprocessed Pi-55(l"M' (not Pri 60gag-P"I) do not selectively package tRNALY, into virus. These particles were produced by transfecting COS-7 cells with DNA construct E(pSVGAG-RRE-R; Fig. 1) (34, 35) . The low-molecular-weight RNA pattern of these virus particles is shown in Fig. 2E , and phosphor-imaging analysis of this pattern (Table 1) indicates that no select tRNALYS incorporation occurs; i.e., 4.7% of the low-molecularweight viral RNA is tRNALYS. We also produced virus particles by transfecting COS-7 cells with DNA construct F [pSVGAG-POL-RRE-R P(-)]. These particles contain both unprocessed P-55-"tg and Pr16W'91""'' (34, 35) . The low-molecular-weight RNA pattern of these virus particles is shown in Fig. 2F , and phosphor-imaging analysis of this pattern (Table 1) indicates that select tRNALYS incorporation occurs; i.e., 50% of the low-molecular-weight viral RNA is tRNAL-Ys. This finding further supports the importance of PrI60q6aig-p'" in tRNALys selection. It should also be noted that construct F produces viral genomic RNA lacking the PBS (as does construct E); therefore, these experiments validate earlier results which indicated that select tRNALYS incorporation into HIV-1 does not require the presence of a PBS on the genomic RNA (16). The results in Fig. 2 and Table I showed the effects of mutations in the viral proteins on the ability to selectively incorporate tRNAL-YS into virions, but these experiments did not address the effects of these mutations on the absolute amounts of tRNALYS incorporated into the virus particles. To investigate this, we measured the tRNA LYs/genomic RNA ratio in each of the RNA samples isolated from the wild-type and mutant viruses ( Fig. 3 and 4 ; Table 2 ).
We have previously demonstrated the ability of a DNA probe complementary to the terminal 3' 18 nucleotides of tRNA LYS to hybridize specifically with this tRNA (16) . Total viral RNAs from wild-type and mutant viruses were blotted onto Hybond filter paper, and the amount of tRNAXLYS present in each sample was determined through hybridization both to these samples and to known amounts of purified human placental tRNA"ys (Fig. 3) . The amount of genomic RNA in each sample was determined by quantitative PCR (Fig. 4) . The results were quantitated by phosphor-imaging analysis ( Table  2) .
We found that wild-type virus contain eight molecules of tRNAkYs per two copies of genomic RNA ( Table 2 , RNA source B). Similar amounts of tRNALYs were found in the protease-negative mutant virus particles (RNA source C). The virions lacking the RT and part of the integrase showed an eightfold reduction in the amount of tRNA3Ys per two copies of genomic RNA (RNA source D). On the other hand, the amount of tRNALys per two copies of genomic RNA ratio was unexpectedly high in virus particles produced from the expression vector producing only PrS559'i (RNA source E), since these particles showed no specificity of tRNALYS incorporation. The amount of tRNA Lys per two copies of genomic RNA was also unexpectedly high in virus particles produced from the expression vector producing both Pr55g'9 and PrI60g'-"'9
(RNA source F). These particles showed specific tRNALYs incorporation, but the amount of tRNA LYs per two copies of genomic RNA was approximately 14 found in wild-type HIV-1. These high ratios could be explained if there was a defect in constructs E and F which resulted in virus particles that had a 10-fold decrease in their ability to package genomic RNA. Recent data suggest that these constructs do produce viral particles defective in the packaging of genomic RNA (3a).
DISCUSSION
As reported above, approximately 60% of viral low-molecular-weight RNA in HIV-1 is tRNALYS, with 30% represented by the primer tRNA, tRNALys. These results are similar to those found for the primer tRNA, tRNATrP, in avian myeloblastosis virus (AMV) by using a very different technique, aminoacylation (39) . Primer tRNATrP represents 32% of free viral tRNA in AMV. We have also determined the amount of tRNA'-Ys and genomic RNA present in HIV-1 total viral RNA and used this information to calculate the number of tRNALys molecules per virion, assuming two copies of genomic RNA per virion. By these calculations, wild-type HIV-1 contains approximately eight molecules of tRNA'-Ys per virion. This number is similar to the value of six to eight molecules of primer tRNA per virion reported for Rous sarcoma virus (33) and AMV (39) .
In this report, we provide evidence supporting the hypothesis that the unprocessed P060v-P"' is involved in selecting tRNALYS for incorporation into HIV-1. First, studies with a protease mutant clearly demonstrate that proteolysis of viral protein precursors is not required for tRNALys incorporation.
A similar conclusion was reached from studies using the MuLV (6) and avian leukemia virus (36) systems.
Second, viral particles containing only unprocessed Pr55-1t9 volumes of RNA samples isolated from virus produced by transfecting COS cells with constructs B to F (see Fig. 1 that RT sequences are involved in tRNALYS selection. It is known that mature RT (p66/pSi) interacts with primer tRNA during reverse transcription (1, 32) , and it has been shown in both the avian sarcoma virus (26) and MuLV (21) (36) and in RT-negative avian and murine retroviruses (21, 26) . Our results are also consistent with our unpublished data (3a) showing that RNA from constructs resembling E and F cannot be packaged into particles. This explains the unexpectedly high ratio of tRNA3YS molecules per two copies of genomic RNA observed in these cases. Particles produced from the plasmid expressing only unprocessed PrS55ag did not show select tRNALYS incorporation yet contained 11 molecules of tRNA3YS per two copies of genomic RNA. Particles produced from the plasmid expressing both unprocessed Pr55rag and Pr1609ag9PI showed selective packaging of tRNALYS but contained 109 molecules of tRNA3LY per two copies of genomic RNA, a ratio 14-fold higher than found in wild-type HIV-1. The 10-fold differences in the ratio of tRNA3YS per two copies of genomic RNA seen between these two viral populations probably reflects a 10-fold difference in tRNALYS selective packaging because of the presence of Pr1609rarP in one and not the other. While it is not clear why the genomic RNA from these constructs fail to be packaged, these results are consistent with recent findings which indicate that the two regions missing in our constructs, the 5' part of the genome through the PBS and the region 3' of the vifgene (34, 35) , are required for genomic RNA packaging (30, 37a) .
The tRNALys/tRNALYs ratios are similar in the cell's cytoplasm and in the virus. This finding indicates that these tRNALYS isoacceptors are packaged with equal efficiency and suggests that some common feature of these molecules is tRNALYs is expected to be complexed with proteins such as lysine tRNALys synthetase or the eukaryotic elongation factor EF-lot, which carries tRNA to the ribosome (15, 23) . It may therefore be that the PrI606"¢" binding site on tRNA3YS is composed of protein as well as RNA.
In a retrovirus, primer tRNA is present in a higher abundance than most other tRNAs. Is this higher abundance a requirement for its efficient function as a primer tRNA, or is efficiency of function as a primer more influenced by specific structural properties of the tRNA? Colicelli and Goff (5) isolated a mutant MuLV which contained a PBS complementary to tRNAG"' rather than tRNAPrO, the normal primer tRNA in this virus. These virus particles were infectious and presumably could use tRNAG'" as the primer tRNA. Similar results were also obtained in which a recombinant MuLVbased retroviral vector containing a PBS for tRNAGIn or tRNALYS instead of tRNAPr"' also appeared to be replicated, using tRNAG In or tRNA Ys as the primer for reverse transcription (22) . The concentration of tRNALYS relative to other viral tRNAs is high in many retroviral systems examined, including MuLV (40) , but the relative concentration of tRNAGln in MuLV has not been reported, and it would be of interest to know whether the select incorporation of tRNAG'" into the mutant virus or in the retroviral vector particles is required for it to act efficiently as a primer for reverse transcription. As mentioned above, evidence is presented here and elsewhere that viral genomic RNA does not appear to be involved in the selective incorporation of primer tRNA, including in the MuLV system (20) .
